 Connection
Javier Valle to Drug Therapy, Combination
This is a "connection" page, showing publications Javier Valle has written about Drug Therapy, Combination.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.289 |
|
|
|
-
Valle JA, Graham L, DeRussy A, Itani K, Hawn MT, Maddox TM. Triple Antithrombotic Therapy and Outcomes in Post-PCI Patients Undergoing Non-cardiac Surgery. World J Surg. 2017 Feb; 41(2):423-432.
Score: 0.118
-
Valle JA, Messenger JC. Triple Therapy...Can We Replace More With Better? J Am Coll Cardiol. 2015 Aug 11; 66(6):628-30.
Score: 0.107
-
Maw AM, Thompson LE, Ho PM, Kennedy KF, Maddox TM, Valle JA, Sandhu A, Masoudi FA, Messerli FH, Daugherty SL. Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project). Am J Cardiol. 2020 01 01; 125(1):63-67.
Score: 0.036
-
Shafiq A, Valle J, Jang JS, Qintar M, Gosch K, Cohen DJ, Singh M, Bach R, Spertus JA. Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non-ST Elevation Myocardial Infarction. J Am Heart Assoc. 2016 06 10; 5(6).
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|